期刊文献+

高效液相色谱法测定普卢利沙星的含量 被引量:3

Content determination of prulixacin by HPLC
下载PDF
导出
摘要 目的建立普卢利沙星的含量测定方法。方法采用高效液相色谱法;Alltima C18柱(150mm×4.6mm,5μm);乙腈:0.005mol/L磷酸二氢钠溶液(取0.005mol/L磷酸二氢钠溶液100ml,加三乙胺0.2ml,用磷酸调节pH值至6.0)(40:60)为动相;流速1.0ml/min,检测波长278nm。结果普卢利沙星在12.8~204.1μg/ml浓度范围内呈现良好的线性关系,r=0.9999.结论该方法快速、简捷、准确都高,适用于普卢利沙星的含量测定。 Objective A high performance liquid chromatographic method for the content determination of prulixacin was developed. Method The HPLC was performed on a column of Alltima C18 (150mm × 4.6mm, 5μm), using the mobile phase of 0.005mol/L sodium dihydrogen phosphate (added with 0. 2ml triethylamine and adjusted to pH 6.0 by phosphoric acid) : acetonitrile (60 : 40) at the detection wavelength of 278nm with the flow rate of 1.0ml/min. Results The calibration curve was linear in the range of 12.8~204.1μg/ml (r=0. 9999) for prulixacin. Conclusion The method was simple, quick and accurate for content determination of prulixacin.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2006年第12期761-761,I0002,共2页 Chinese Journal of Antibiotics
关键词 普卢利沙星 含量测定 HPLC法 Prulixacin Content determination HPLC
  • 相关文献

参考文献4

  • 1方利明,金艳,魏敏吉.氟喹诺酮类抗菌剂——普卢利沙星[J].中国医药导刊,2004,6(3):225-227. 被引量:20
  • 2Prats G, Roig C, Miro E, et al. In vitro activity of the active metabolite of prulifloxacin (AF 3013) compared with six other fluoroquinolones [J]. Eur J Clin Microbiol Infect Dis, 2002,21 (4) : 328
  • 3Kakemi K, Aoki N, Mikawa M, et al. Chemical structure, physicochemical properties and stability of prulifloxacin[J]. Iyakuhin Kenkyu,1997 ,28(1):1.
  • 4绳金房,李巍,谭娅娅,杨欣.HPLC法测定普卢利沙星的含量[J].中国抗生素杂志,2005,30(10):594-596. 被引量:2

二级参考文献19

  • 1王金生,宋慈媛.新氟喹诺酮抗菌药NM441[J].国外医药(抗生素分册),1996,17(3):224-226. 被引量:11
  • 2夏建民.抗菌新药普利沙星[J].上海医药,1996(11):24-24. 被引量:7
  • 3Carlo Grassi, Enrica Salvatori, Maria Teresa Rosignoli, et al. Randomized, double - blind study of prulifioxacin versus ciprofloxacin in patients with Acut Exacerbations of Chronic Bronchitis. Respiration,2002; 69: 217~222
  • 4Maria Pia Montanari, Marina Mingoia, Pietro Emanuele Varaldo. In vitro antibacterial activities of AF3013, the actice metabolite of prulifloxacin, against nosocomial and community Italian isolates. Antimicrob Agents Chemother, 2001; 45(12): 3616~ 3622
  • 5Yoshio Okuyama, Kazuo Momota, Akira Morino. Pharmacokinetics of prudifloxacin 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single admiustration. Arzneim. Forsch./Drug Res, 1997; 47(Ⅰ): 276~ 284
  • 6Kura K, Fukui H, Fukui T, et al. General pharmacological studies of NM441 (1). Effect on center and peripheral nervous systems, gastrointestinal tract and smooth muscle. Jpn J Chemother, 1996; 44(Suppl.1): 113~ 128
  • 7Masakuni Ozaki, Masato Matsuda, Yoshifumi Tomii, et al. In vivo evaluation of NM441, a new thiazeto - quinoline derivative. Antimicrob Agents Chemother, 1991; 35(12): 2496- 2499
  • 8Katsuhiko Tougou, Akio Nakamura, Shuji Watanabe, et al. Paraoxonase has a major role in the hydrolysis of prulifloxacin(NM441), a prodrug of a new antibacterial agent. Drug Metab Dispos, 1998; 26:355- 359
  • 9vRossella Picollo, Nils Brion, Virginie Gualano, et al. Pharmacokinetics and tolerability of prulifloxacin after single oral administration.Arzneim. - Forsch./Drug Res, 2003; 53(3): 201 - 205
  • 10Masakuni Ozaki, Masato Matsuda, Yoshifumi Tomii, et al. In vitro antibacterial activity of a new quinolne, NM394. Antimicrob Agents Chemother, 1991;35(12): 2490- 2495

共引文献20

同被引文献19

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部